Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Liquidia Corp
(NQ:
LQDA
)
11.49
-0.06 (-0.52%)
Streaming Delayed Price
Updated: 1:44 PM EDT, Jul 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Liquidia Corp
< Previous
1
2
Next >
Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA™ (treprostinil) Inhalation Powder
July 27, 2023
From
Liquidia Corporation
Via
GlobeNewswire
U.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation
July 24, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America
June 28, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Present at the 2023 Jefferies Healthcare Conference
May 31, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Announces Poster Presentation at the 2023 American Thoracic Society International Conference
May 19, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 04, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Present at BofA Securities 2023 Health Care Conference
May 02, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023
April 27, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications
April 03, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Reports Full Year 2022 Financial Results and Provides Corporate Update
March 16, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023
March 09, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
February 02, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 02, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million
January 09, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)
December 05, 2022
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 08, 2022
Company to host webcast and conference call today at 8:30 a.m. ET
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia to Report Third Quarter 2022 Financial Results on November 8, 2022
November 01, 2022
From
Liquidia Corporation
Via
GlobeNewswire
Precedential Opinion Panel Denies United Therapeutics’ Request for Review of ‘793 Inter Partes Review Decision
October 27, 2022
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Announces Presentations at the CHEST 2022 Annual Meeting
October 17, 2022
From
Liquidia Corporation
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.